title: Treatment of chronic hepatitis C in a patient with systemic lupus erythematosus.
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Péron
authors.forename: Laurent
authors.initials: L
authors.lastname: Zabraniechki
authors.forename: François
authors.initials: F
authors.lastname: Pey
authors.forename: Christophe
authors.initials: C
authors.lastname: Bureau
authors.forename: Séverine
authors.initials: S
authors.lastname: Valmary
authors.forename: Laurent
authors.initials: L
authors.lastname: Alaric
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Vinel
mesh_terms: D000368:Aged; D000740:Anemia / Q000139:chemically induced; D000998:Antiviral Agents / Q000627:therapeutic use*; D001247:Asthenia / Q000139:chemically induced; D004359:Drug Therapy, Combination; D005260:Female; D006261:Headache / Q000139:chemically induced; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000821:virology; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin